• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, July 29, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

New insight could improve maternal vaccines that also protect newborns

Bioengineer by Bioengineer
June 13, 2019
in Immunology
Reading Time: 2 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Understanding how a mother’s antibodies are passed to the fetus is key to vaccine design

DURHAM, N.C. – A team led by Duke Health scientists has identified a cellular process that could lead to the development of safer and more effective vaccines that protect pregnant women as well as their newborns from dangerous infections.

Publishing online June 13 in the journal Cell, the researchers describe a previously unidentified route for antibodies to be transferred from the mother to the fetus, illuminating a potential way to capitalize on this process to control when and how certain antibodies are shared.

“It’s always been assumed that the types of maternal antibodies that cross over the placenta to the fetus, all antibodies had the same chance of transferring to fetus,” said senior author Sallie Permar, M.D., Ph.D., a professor of pediatrics and member of the Duke Human Vaccine Institute.

“This meant there was no way we could direct certain antibodies across the placenta and to the baby,” Permar said. “Our study found that there seems to be a code on the antibody that determines which antibodies will more effectively transfer across the placenta.”

Permar and colleagues — including co-senior author Genevieve Fouda, Ph.D., and lead author David Martinez, Ph.D. — studied two populations of pregnant women in the United States and Malawi who were infected with HIV, which is known to inhibit the transfer of antibodies to the fetus – and not just HIV antibodies. This feature provided a unique circumstance to explore a little-understood process with implications for numerous common pathogens, including tetanus, pertussis, influenza and others.

The researchers identified a sugar molecule that interacts with placental receptors, an interaction that had previously not been known to be involved in the antibody transfer process. The finding was corroborated in healthy women by another research team publishing in the same issue of Cell.

“We have shown that the efficiency of antibody transfer across the placenta is differentially regulated,” Permar said. “This insight could improve the design of vaccines for a variety of infectious diseases to improve the transplacental antibody transfer to the fetus.”

“Our findings provide a roadmap of how antibodies cross the placenta to the baby,” Martinez said. “We hope our results will be useful for developing antibody therapeutics that protect infants against infectious diseases in early life.”

###

In addition to Permar, Fouda and Martinez, study authors include Youyi Fong, Shuk Hang Li, Fang Yang, Madeleine Jennewein, Joshua A. Weiner, Erin A. Harrell, Jesse F. Mangold, Ria Goswami, George Seage, Galit Alter, Margaret E. Ackerman and Xinxia Peng.

The study was partially funded through a grant from the National Institute of Child Health and Human Development (HD085871) and grants from the National Institute of Allergy and Infectious Diseases (F31 AI127303, U01 AI068632, DP2 HD075699, R01 AI106380, P01 AI117915). A full disclosure of grant support is provided in the study manuscript.

Media Contact
Sarah Avery
[email protected]

Tags: AIDS/HIVDisease in the Developing WorldImmunology/Allergies/AsthmaInfectious/Emerging DiseasesMedicine/HealthVaccinesVirology
Share12Tweet7Share2ShareShareShare1

Related Posts

IMAGE

UMass Amherst grad student awarded fellowship for food allergy research

July 23, 2021
IMAGE

Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested

July 22, 2021

Public trust in CDC, FDA, and Fauci holds steady, survey shows

July 20, 2021

USC study shows male-female differences in immune cell function

July 19, 2021
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    54 shares
    Share 22 Tweet 14
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    42 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    45 shares
    Share 18 Tweet 11
  • Engineered Cellular Communication Enhances CAR-T Therapy Effectiveness Against Glioblastoma

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Novel Plasma Synuclein Test Advances Parkinson’s Diagnosis

Advancing Microbial Risk Assessment Through Detection Technology Evolution

Obesity’s Impact on Pancreatic Surgery Outcomes Compared

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.